May 19, 2026

Risen Pharma Announces Initiation of Phase 2 Clinical Trial of RP902 for Mild Cognitive Impairment Due to Alzheimer’s Disease

SHANGHAI, May 19, 2026 (GLOBE NEWSWIRE) — Risen Pharma, a clinical-stage biotech company focusing on the development and commercialization of high-need, patient-accessible therapeutics, today announced the initiation of a Phase 2 clinical study in China of RP902, an oral small-molecule drug developed to address significant unmet medical needs in patients with Alzheimer’s disease. The Phase 2 […]

Read More »

Bitget Launches UEX Jumpstart Program With 430K USDT Rewards

Bitget Launches UEX Jumpstart Program With 430K USDT Rewards VICTORIA, Seychelles, May 19, 2026 (GLOBE NEWSWIRE) — Bitget, the world’s largest Universal Exchange (UEX), has launched the UEX Jumpstart Program, a multi-product onboarding initiative featuring a total prize pool of 430,000 USDT across crypto futures, precious metals, stocks and CFDs. Running from May through June, the […]

Read More »

Amii Fuels Canada’s AI Momentum as Upper Bound Opens with 53% Growth and 11,000 Global Attendees

Canada’s fastest-growing AI event sells out a month in advance, cementing Edmonton as a global anchor for AI innovation and literacy EDMONTON, Alberta, May 19, 2026 (GLOBE NEWSWIRE) — Amii (Alberta Machine Intelligence Institute) today officially opens the fifth annual Upper Bound, the premier AI conference that has surpassed all projections to become a cornerstone of the […]

Read More »